These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
76 related items for PubMed ID: 17332362
1. New soft alkylating agents with enhanced cytotoxicity against cancer cells resistant to chemotherapeutics and hypoxia. Patenaude A, Deschesnes RG, Rousseau JL, Petitclerc E, Lacroix J, Côté MF, C-Gaudreault R. Cancer Res; 2007 Mar 01; 67(5):2306-16. PubMed ID: 17332362 [Abstract] [Full Text] [Related]
6. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule. Liou JP, Hsu KS, Kuo CC, Chang CY, Chang JY. J Pharmacol Exp Ther; 2007 Oct 01; 323(1):398-405. PubMed ID: 17660383 [Abstract] [Full Text] [Related]
9. Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms. Wang Y, Yin S, Blade K, Cooper G, Menick DR, Cabral F. Biochemistry; 2006 Jan 10; 45(1):185-94. PubMed ID: 16388594 [Abstract] [Full Text] [Related]
11. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways. Chen YC, Lu PH, Pan SL, Teng CM, Kuo SC, Lin TP, Ho YF, Huang YC, Guh JH. Biochem Pharmacol; 2007 Jun 30; 74(1):10-9. PubMed ID: 17475221 [Abstract] [Full Text] [Related]
12. N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer. Wang YM, Hu LX, Liu ZM, You XF, Zhang SH, Qu JR, Li ZR, Li Y, Kong WJ, He HW, Shao RG, Zhang LR, Peng ZG, Boykin DW, Jiang JD. Clin Cancer Res; 2008 Oct 01; 14(19):6218-27. PubMed ID: 18829501 [Abstract] [Full Text] [Related]
13. Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole. Chu SW, Badar S, Morris DL, Pourgholami MH. Anticancer Res; 2009 Oct 01; 29(10):3791-6. PubMed ID: 19846910 [Abstract] [Full Text] [Related]
16. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, Lu Z, Chen Q, Lai Y, Pan J. Clin Cancer Res; 2009 Mar 01; 15(5):1686-97. PubMed ID: 19240172 [Abstract] [Full Text] [Related]
17. A new generation of N-aryl-N'-(1-alkyl-2-chloroethyl)ureas as microtubule disrupters: synthesis, antiproliferative activity, and beta-tubulin alkylation kinetics. Mounetou E, Legault J, Lacroix J, C -Gaudreault R. J Med Chem; 2003 Nov 06; 46(23):5055-63. PubMed ID: 14584955 [Abstract] [Full Text] [Related]
19. Antitumor triptycene analogs directly interact with isolated mitochondria to rapidly trigger markers of permeability transition. Perchellet EM, Wang Y, Lou K, Zhao H, Battina SK, Hua DH, Perchellet JP. Anticancer Res; 2007 Nov 06; 27(5A):3259-71. PubMed ID: 17970069 [Abstract] [Full Text] [Related]
20. Intra-allelic suppression of a mutation that stabilizes microtubules and confers resistance to colcemid. Wang Y, Veeraraghavan S, Cabral F. Biochemistry; 2004 Jul 20; 43(28):8965-73. PubMed ID: 15248754 [Abstract] [Full Text] [Related] Page: [Next] [New Search]